🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT06183424
Recruiting Not applicable

TDCS Stimulation After Covid-19 Infection

NCT06183424 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2023-10-01
Last updated
2025-05-02

Condition(s) studied

COVID-19

Investigational drug(s) / intervention(s)

Transcranial Direct Stimulation

Transcranial Direct Stimulation: 2 mA, 20 min, 5 days

Study summary

In this study, the effects of bilateral stimulation of the dorsolateral prefrontal cortex (DLPFC) with active tDCS (transcranial direct stimulation/transcranial direct stimulation) on neurocognitive (memory and executive) functions in patients with Covid-19 infection and subjective cognitive complaints, as well as resting-state fMRI In the case of dfMRI, it is aimed to examine the default mode network (DMN) and parietal memory network (PMN) inter- and intra-network connectivity alterations and the hippocampal region connectivity alterations and contribute to the relevant literature.

Eligibility

Sex
ALL
Min age
18 Years
Max age
50 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Have received a positive value from the COVID-19 RT-PCR test in the last 60 days and turned negative * Being between the ages of 18-50 * 21 days have passed since the disease onset date Exclusion Criteria: * Having any neurological or psychiatric disease

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Alanya Alaaddin Keykubat Üniversitesi Antalya Turkey (Türkiye) Recruiting

More Istanbul Medipol University Hospital trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06183424 on ClinicalTrials.gov ↗ ← All trials in Turkey